Lilly Delivers Strong Third-Quart...(e the company's latest Form 10-Q filedAu...),Health

Actos(R) (pioglitazone hydrochloride, Takeda)

Alimta(R) (pemetrexed, Lilly)

Byetta(R) (exenatide injection, Amylin Pharmaceuticals)

Cialis(R) (tadalafil, Lilly)

Cymbalta(R) (duloxetine hydrochloride, Lilly)

Evista(R) (raloxifene hydrochloride, Lilly)

Forteo(R) (teriparatide of recombinant DNA origin injection, Lilly)

Gemzar(R) (gemcitabine hydrochloride, Lilly)

Humalog(R) (insulin lispro injection of recombinant DNA origin, Lilly)

Humulin(R) (human insulin of recombinant DNA origin, Lilly)

KwikPen(TM)

Strattera(R) (atomoxetine hydrochloride, Lilly)

Symbyax(R) (olanzapine fluoxetine combination, or OFC, Lilly)

Xigris(R) (drotrecogin alfa (activated), Lilly)

Yentreve(R) (duloxetine hydrochloride, Lilly)

Zyprexa(R) (olanzapine, Lilly)

Eli Lilly and Company Employment Information

September 30, 2007 December 31, 2006

Worldwide Employees 41,000* 41,500

*Headcount figures as of September 30, 2007 include certain personnel previously employed by Icos Corporation, Hypnion, Inc. and Ivy Animal Health, Inc.

Eli Lilly and Company

Operating Results (Unaudited) - REPORTED

(Dollars in millions, except per share data)

Three Months Nine Months

Ended Sept. 30 Ended Sept. 30

2007 2006 % Chg. 2007 2006 % Chg.

------------------------ -------------------------

Net sales $ 4,586.8 $3,864.1 19% $13,443.9 $11,445.7 17%

Cost of sales 1,054.6 860.4 23% 2,976.0 2,527.5 18%

Research and

development 844.5 7
'/>"/>